Alumis Inc. (ALMS) stock
ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.39−0.45 (-9.19%)
Close on Nov 18, 2026Market cap $568.87MP/E –Yield –
Alumis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Alumis's revenue for the twelve months ending Jun 30, 2026 was $7.40M. For fiscal 2025 it was $24.05M.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.05M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.66M | -37.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.74M | -90.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.93M | – |
| Q3 FY2025 | Sep 30, 2025 | $2.07M | – |
| Q2 FY2025 | Jun 30, 2025 | $2.67M | – |
| Q1 FY2025 | Mar 31, 2025 | $17.39M | – |
See a number that looks wrong?